SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-019460
Filing Date
2018-11-05
Accepted
2018-11-05 07:31:42
Documents
47
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20180930_10q.htm 10-Q 487213
2 EXHIBIT 31.1 ex_127447.htm EX-31.1 14109
3 EXHIBIT 31.2 ex_127448.htm EX-31.2 14112
4 EXHIBIT 32.1 ex_127449.htm EX-32.1 4943
5 EXHIBIT 32.2 ex_127450.htm EX-32.2 5198
  Complete submission text file 0001437749-18-019460.txt   2809855

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snbp-20180930.xml EX-101.INS 440707
7 XBRL TAXONOMY EXTENSION SCHEMA snbp-20180930.xsd EX-101.SCH 35187
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snbp-20180930_cal.xml EX-101.CAL 27099
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snbp-20180930_def.xml EX-101.DEF 249844
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snbp-20180930_lab.xml EX-101.LAB 215852
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snbp-20180930_pre.xml EX-101.PRE 265288
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55242 | Film No.: 181158751
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences